NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
2.
IzzedineHMercadalLAymardGLaunay-VacherVMartinezVIssadBNeurotoxicity of valacyclovir in peritoneal dialysis: A pharmacokinetic study. Am J Nephrol2001;21:162–4.
3.
Linssen-SchuurmansCDvan KanEJFeithGWUgesDR. Neurotoxicity caused by valacyclovir in a patient on hemodialysis. Ther Drug Monit1998;20:385–6.
4.
OkadaTNakaoTMatsumotoHNagaokaYIwasawaHNanriKValacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis. Clin Nephrol2002;58:168–70.
5.
BanesD.Valacyclovir neurotoxicity: Two case reports and a review of the literature. Can J Hosp Pharm2002;55:123–7.
